Inflammation-associated diseases encompass a range of infectious diseases and non-
infectious inflammatory diseases, which continuously pose one of the most serious threats to …

SARS-CoV-2, the virus underlying COVID-19, has now been recognized to cause
multiorgan disease with a systemic effect on the host. To effectively combat SARS-CoV-2 …

Exposure to ubiquitous plastic-associated endocrine disrupting chemicals (EDCs) is
associated with the increased risk of many chronic diseases. For example, phthalate …

New variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are
continuing to spread globally, contributing to the persistence of the COVID-19 pandemic …

The global COVID-19 pandemic arising from SARS-CoV-2 has impacted many lives, gaining
interest worldwide ever since it was first identified in December 2019. Till 2023, 752 million …

Background Health disparities in underserved communities, such as inadequate healthcare
access, impact COVID-19 disease outcomes. These disparities are evident in Hispanic …

Current tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detect
either the constituent nucleic acids/proteins of the viral particles or antibodies specific to the …

Plastic-associated endocrine disrupting chemicals (EDCs) have been implicated in the
etiology of cardiovascular disease (CVD) in humans, but the underlying mechanisms remain …

More than 2 years have passed since the SARS-CoV-2 outbreak began, and many
challenges that existed at the beginning of this pandemic have been solved. Some countries …

Biomaterials with antimicrobial activity are gaining attention due to their biodegradability and
efficacy in interacting with a wide range of microorganisms. A new cellulose nano …